Discontinued — last reported Q3 '22

Products & Services · Insurance Services Revenue

IngenioRx Segment — Insurance Services Revenue

Elevance Health IngenioRx Segment — Insurance Services Revenue increased by 11.4% to $3.97B in Q3 2022 compared to the prior quarter. Year-over-year, this metric grew by 17.9%, from $3.37B to $3.97B. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ3 2019
Last reportedQ3 2022

How to read this metric

An increase indicates growth in member enrollment, higher drug utilization, or successful expansion of pharmacy services to new clients.

Detailed definition

This represents the total revenue generated from pharmacy benefit management services provided to health plan members an...

Peer comparison

Directly comparable to PBM revenue streams at other major health insurers or standalone pharmacy benefit managers.

Metric ID: elv_segment_ingeniorx_segment_insurance_services_revenue

Historical Data

5 periods
 Q2 '21Q3 '21Q1 '22Q2 '22Q3 '22
Value$3.04B$3.37B$3.30B$3.57B$3.97B
QoQ Change+10.7%-2.0%+8.0%+11.4%
YoY Change+17.2%+17.9%
Range$3.04B$3.97B
CAGR+30.5%
Avg YoY Growth+17.5%
Median YoY Growth+17.5%
Current Streak2 quarters growth

Frequently Asked Questions

What is Elevance Health's ingeniorx segment — insurance services revenue?
Elevance Health (ELV) reported ingeniorx segment — insurance services revenue of $3.97B in Q3 2022.
How has Elevance Health's ingeniorx segment — insurance services revenue changed year-over-year?
Elevance Health's ingeniorx segment — insurance services revenue increased by 17.9% year-over-year, from $3.37B to $3.97B.
What does ingeniorx segment — insurance services revenue mean?
Total revenue earned from providing pharmacy benefit management services.